Brain, the major organ of the central nervous system controls and processes most of body
activities. Therefore, the most aggressive brain tumor–glioblastoma and metastases from …

The cellular environment where tumor cells reside is called the tumor microenvironment
(TME), which consists of borders, blood vessels, lymph vessels, extracellular matrix (ECM) …

Simple Summary Among primary brain tumours, glioblastoma is the most aggressive. As
early relapses are unavoidable despite standard-of-care treatment, the cannabinoids delta-9 …

Angiogenesis is required in cancer, including gynecological cancers, for the growth of
primary tumors and secondary metastases. Development of anti-angiogenesis therapy in …

The poor response of glioblastoma to current treatment protocols is a consequence of its
intrinsic drug resistance. Resistance to chemotherapy is primarily associated with …

Glioma, which accounts for more than 30% of primary central nervous system tumours, is
characterised by symptoms such as headaches, epilepsy, and blurred vision. Glioblastoma …

Glioblastoma multiforme (GBM) is a highly heterogeneous disease with a mesenchymal
subtype tending to exhibit more aggressive and multitherapy-resistant features …

Glioblastomas remain the most lethal primary brain tumors. Natural killer (NK) cell-based
therapy is a promising immunotherapeutic strategy in the treatment of glioblastomas, since …

Mesenchymal stem cells (MSCs) are among the most investigated and applied somatic stem
cells in experimental therapies for the regeneration of damaged tissues. Moreover, as it was …

Diffuse gliomas are primary brain tumors associated with a poor prognosis. Cellular and
molecular mechanisms driving the invasive growth patterns and therapeutic resistance are …